| William A Paczkowski, NP | |
|
281 Cusick Rd, Alcoa, TN 37701 | |
| (865) 970-0025 | |
| (865) 970-2089 |
| Full Name | William A Paczkowski |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner |
| Experience | 7 Years |
| Location | 281 Cusick Rd, Alcoa, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205327103 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 24254 (Tennessee) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | 24254 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Tn Medical Center | Knoxville, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ut Urgent Care Centers, Llc | 5597015065 | 23 |
News Archive
Because Medicare beneficiaries account "for the vast majority of U.S. deaths" the treatment people receive "in the last year of life accounts for roughly a quarter of Medicare's budget." Dr. Joel Policzer, a medical director for a hospice, says that often "a dying elderly patient may have wanted less invasive care. But it doesn't happen.
We all know that if we don't get enough sleep or don't sleep well, we won't be on top of our game the next day.
Those looking for a new treatment for a range of inflammatory diseases like arthritis, multiple sclerosis, inflammatory bowel disease, and lupus may need to look no further than a drug already available for treating cancer. In a research report published in the July 2010 print issue of the Journal of Leukocyte Biology, Japanese scientists use mice to show that bortezomib, currently used to treat cancers that affect white blood cells, induces cell death only in harmful (active and proliferating) T cells, leaving the rest unharmed.
An international panel of leading scientists is launching a new TripAdvisor-style website aimed at helping researchers choose better-quality research tools - and avoiding potentially serious errors in biomedical research.
› Verified 9 days ago
| Entity Name | University Health System, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790738763 PECOS PAC ID: 5294646378 Enrollment ID: O20031111000809 |
News Archive
Because Medicare beneficiaries account "for the vast majority of U.S. deaths" the treatment people receive "in the last year of life accounts for roughly a quarter of Medicare's budget." Dr. Joel Policzer, a medical director for a hospice, says that often "a dying elderly patient may have wanted less invasive care. But it doesn't happen.
We all know that if we don't get enough sleep or don't sleep well, we won't be on top of our game the next day.
Those looking for a new treatment for a range of inflammatory diseases like arthritis, multiple sclerosis, inflammatory bowel disease, and lupus may need to look no further than a drug already available for treating cancer. In a research report published in the July 2010 print issue of the Journal of Leukocyte Biology, Japanese scientists use mice to show that bortezomib, currently used to treat cancers that affect white blood cells, induces cell death only in harmful (active and proliferating) T cells, leaving the rest unharmed.
An international panel of leading scientists is launching a new TripAdvisor-style website aimed at helping researchers choose better-quality research tools - and avoiding potentially serious errors in biomedical research.
› Verified 9 days ago
| Entity Name | Ut Urgent Care Centers, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801391453 PECOS PAC ID: 5597015065 Enrollment ID: O20180904001336 |
News Archive
Because Medicare beneficiaries account "for the vast majority of U.S. deaths" the treatment people receive "in the last year of life accounts for roughly a quarter of Medicare's budget." Dr. Joel Policzer, a medical director for a hospice, says that often "a dying elderly patient may have wanted less invasive care. But it doesn't happen.
We all know that if we don't get enough sleep or don't sleep well, we won't be on top of our game the next day.
Those looking for a new treatment for a range of inflammatory diseases like arthritis, multiple sclerosis, inflammatory bowel disease, and lupus may need to look no further than a drug already available for treating cancer. In a research report published in the July 2010 print issue of the Journal of Leukocyte Biology, Japanese scientists use mice to show that bortezomib, currently used to treat cancers that affect white blood cells, induces cell death only in harmful (active and proliferating) T cells, leaving the rest unharmed.
An international panel of leading scientists is launching a new TripAdvisor-style website aimed at helping researchers choose better-quality research tools - and avoiding potentially serious errors in biomedical research.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| William A Paczkowski, NP 9000 Executive Park Dr Ste C200, Knoxville, TN 37923-4644 Ph: (865) 670-6754 | William A Paczkowski, NP 281 Cusick Rd, Alcoa, TN 37701 Ph: (865) 970-0025 |
News Archive
Because Medicare beneficiaries account "for the vast majority of U.S. deaths" the treatment people receive "in the last year of life accounts for roughly a quarter of Medicare's budget." Dr. Joel Policzer, a medical director for a hospice, says that often "a dying elderly patient may have wanted less invasive care. But it doesn't happen.
We all know that if we don't get enough sleep or don't sleep well, we won't be on top of our game the next day.
Those looking for a new treatment for a range of inflammatory diseases like arthritis, multiple sclerosis, inflammatory bowel disease, and lupus may need to look no further than a drug already available for treating cancer. In a research report published in the July 2010 print issue of the Journal of Leukocyte Biology, Japanese scientists use mice to show that bortezomib, currently used to treat cancers that affect white blood cells, induces cell death only in harmful (active and proliferating) T cells, leaving the rest unharmed.
An international panel of leading scientists is launching a new TripAdvisor-style website aimed at helping researchers choose better-quality research tools - and avoiding potentially serious errors in biomedical research.
› Verified 9 days ago